These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18773064)

  • 1. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?
    Buc E; Lesurtel M; Belghiti J
    HPB (Oxford); 2008; 10(2):98-105. PubMed ID: 18773064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma.
    Chung DT; Tang CN; Lai EC; Yang GP; Li MK
    Hong Kong Med J; 2010 Apr; 16(2):149-52. PubMed ID: 20354252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
    Lin J; Cummings OW; Greenson JK; House MG; Liu X; Nalbantoglu I; Pai R; Davidson DD; Reuss SA
    Scand J Gastroenterol; 2015 Apr; 50(4):447-53. PubMed ID: 25635498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
    Khoshpouri P; Habibabadi RR; Hazhirkarzar B; Ameli S; Ghadimi M; Ghasabeh MA; Menias CO; Kim A; Li Z; Kamel IR
    Radiographics; 2019; 39(7):1938-1964. PubMed ID: 31626561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization.
    Katabathina VS; Dasyam AK; Dasyam N; Hosseinzadeh K
    Radiographics; 2014; 34(3):565-86. PubMed ID: 24819781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.
    Erdogan D; Kloek JJ; ten Kate FJ; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
    Br J Surg; 2008 Jun; 95(6):727-34. PubMed ID: 18418862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal biliopathy: a multitechnique imaging approach.
    Besa C; Cruz JP; Huete A; Cruz F
    Abdom Imaging; 2012 Feb; 37(1):83-90. PubMed ID: 21681494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G; Cristoferi L; Strazzabosco M; Fabris L
    Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass-Forming Portal Biliopathy Presenting as Extreme Wall-Thickening of the Common Bile Duct.
    Hulshoff JB; Cuperus FJC; de Haas RJ
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32842665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.
    Nguyen Canh H; Harada K
    Med Mol Morphol; 2016 Dec; 49(4):189-202. PubMed ID: 27350291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
    Bowlus CL; Lim JK; Lindor KD
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulomatous cholangitis mimicking hilar cholangiocarcinoma: a case report.
    Fujisaki S; Takashina M; Sakurai KI; Tomita R; Takayama T
    BMC Gastroenterol; 2020 Nov; 20(1):369. PubMed ID: 33148196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
    Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
    Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for non-transplant surgery in primary sclerosing cholangitis.
    Domajnko B; Ahrendt SA
    HPB (Oxford); 2005; 7(4):292-7. PubMed ID: 18333210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.